Parallel approaches to the discovery of novel BRD4 inhibitors

被引：0

作者：

Jones, David H. ^{[1
]}

de Groot, Marcel J. ^{[1
]}

Heald, Robert ^{[1
]}

Arhin, Ebenezer ^{[1
]}

Goodwin, Ria ^{[1
]}

Burton, Brenda ^{[1
]}

Kulagowski, Jan ^{[1
]}

Brown, David ^{[1
]}

Irving, Steven ^{[1
]}

Bazin, Richard ^{[1
]}

Bruce, Deborah ^{[1
]}

Devos, Rene ^{[1
]}

Price, Steven ^{[1
]}

Ray, Nick ^{[1
]}

Lockey, Peter ^{[1
]}

Montana, John ^{[1
]}

Albertella, Mark R. ^{[1
]}

Green, Simon R. ^{[1
]}

机构：

[1] Argenta, Harlow, Essex, England

来源：

CANCER RESEARCH | 2014年 / 74卷 / 19期

关键词：

D O I：

10.1158/1538-7445.AM2014-5137

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5137

引用

页数：1

共 50 条

[41] Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery
Liang, Dailin
Yu, Yifan
Ma, Zonghui
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200
[42] Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors
Qiao, Xue-Peng
Wang, Xue-Ting
Wang, Shuai
Mu, Hong-Xia
Wang, Qing-Shan
Ab, Shi-Wu Chen
BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 106
[43] A patent review of BRD4 inhibitors (2013-2019)
Lu, Tian
Lu, Wenchao
Luo, Cheng
EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (01) : 57 - 81
[44] Discovery of novel small molecules that recruit DCAF11 for selective degradation of BRD4
Parker, G.
Toth, J.
Leriche, G.
Fish, S.
Jamborcic, A.
Blanco, G.
Daniele, E.
Steadman, K.
Li, X.
Yang, L.
Chien, S.
Dearie, A.
Chng, K.
Green, E.
Hocker, M.
Zhang, Y.
Thompson, P.
Bailey, S.
EUROPEAN JOURNAL OF CANCER, 2022, 174 : S81 - S81
[45] A patent review of BRD4 inhibitors (2020-present)
Chen, Yanfang
Zhou, Huanmin
Yu, Jiamin
Gao, Jing
Xue, Shengyu
Ding, Hong
Lin, Hua
Luo, Cheng
EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 35 (04) : 371 - 386
[46] Pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation for the discovery of novel BRD4 inhibitors
Yan, Guoyi
Hou, Manzhou
Luo, Jiang
Pu, Chunlan
Hou, Xueyan
Lan, Suke
Li, Rui
CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 91 (02) : 478 - 490
[47] BRD4 is a novel therapeutic target for liver fibrosis
Ding, Ning
Hah, Nasun
Yu, Ruth T.
Sherman, Mara H.
Benner, Chris
Leblanc, Mathias
He, Mingxiao
Liddle, Christopher
Downes, Michael
Evans, Ronald M.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (51) : 15713 - 15718
[48] Charting the Bromodomain BRD4: Towards the Identification of Novel Inhibitors with Molecular Similarity and Receptor Mapping
Prieto-Martinez, Fernando D.
Medina-Franco, Jose L.
LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (09) : 1002 - 1011
[49] Design, synthesis, and anticancer evaluation of ammosamide B with pyrroloquinoline derivatives as novel BRD4 inhibitors
Li, Wen
Zhang, Cheng
Zhang, Hong-en
Dong, Ru
Liu, Jing-ying
Wang, Chun-meng
Wang, Min
Wang, Yu-wei
Wang, Chao
Zhang, Yan
Shi, Lei
Xu, Yong
Sun, Li-Ping
BIOORGANIC CHEMISTRY, 2022, 127
[50] Identification of a novel class of BRD4 inhibitors by high-throughput computational structural biology
Allen, Bryce
Mehta, Saurabh
Ayad, Nagi
Schuerer, Stephan
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251

← 1 2 3 4 5 →